AKTX Stock Summary and Trading Ideas (Akari Therapeutics PLC - American Depositary Shares | NASDAQ:AKTX)

Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).

Akari Therapeutics PLC - American Depositary Shares trades on the NASDAQ stock market under the symbol AKTX.

As of April 19, 2024, AKTX stock price declined to $1.17 with 3,740 million shares trading.

AKTX has a market cap of $5.90 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, AKTX stock traded as high as $54.80 and as low as $1.08.

AKTX has underperformed the market in the last year with a price return of -73.5% while the SPY ETF gained +21.2%. AKTX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -61.3% and -19.0%, respectively, while the SPY returned +4.3% and -3.5%, respectively.

AKTX support price is $1.10 and resistance is $1.32 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AKTX stock will trade within this expected range on the day.